Global Chronic Obstructive Pulmonary Disease Drugs Market Research Report 2019

Table of Contents

Executive Summary

1 Chronic Obstructive Pulmonary Disease Drugs Market Overview

• 1.1 Product Overview and Scope of Chronic Obstructive Pulmonary Disease Drugs
• 1.2 Chronic Obstructive Pulmonary Disease Drugs Segment by Type
  • 1.2.1 Global Chronic Obstructive Pulmonary Disease Drugs Production Growth Rate Comparison by Type (2014-2025)
  • 1.2.2 Inhalers
  • 1.2.3 Nebulizers
• 1.3 Chronic Obstructive Pulmonary Disease Drugs Segment by Application
  • 1.3.1 Chronic Obstructive Pulmonary Disease Drugs Consumption Comparison by Application (2014-2025)
  • 1.3.2 Emphysema
  • 1.3.3 Chronic Bronchitis
  • 1.3.4 Refractory Asthma
  • 1.3.5 Others
• 1.4 Global Chronic Obstructive Pulmonary Disease Drugs Market by Region
  • 1.4.1 Global Chronic Obstructive Pulmonary Disease Drugs Market Size Region
  • 1.4.2 North America Status and Prospect (2014-2025)
  • 1.4.3 Europe Status and Prospect (2014-2025)
  • 1.4.4 China Status and Prospect (2014-2025)
  • 1.4.5 Japan Status and Prospect (2014-2025)
• 1.5 Global Chronic Obstructive Pulmonary Disease Drugs Market Size
  • 1.5.1 Global Chronic Obstructive Pulmonary Disease Drugs Revenue (2014-2025)
  • 1.5.2 Global Chronic Obstructive Pulmonary Disease Drugs Production (2014-2025)

2 Global Chronic Obstructive Pulmonary Disease Drugs Market Competition by Manufacturers

• 2.1 Global Chronic Obstructive Pulmonary Disease Drugs Production Market Share by Manufacturers (2014-2019)
• 2.2 Global Chronic Obstructive Pulmonary Disease Drugs Revenue Share by Manufacturers (2014-2019)
• 2.3 Global Chronic Obstructive Pulmonary Disease Drugs Average Price by Manufacturers (2014-2019)
• 2.4 Manufacturers Chronic Obstructive Pulmonary Disease Drugs Production Sites, Area Served, Product Types
• 2.5 Chronic Obstructive Pulmonary Disease Drugs Market Competitive Situation and Trends
  • 2.5.1 Chronic Obstructive Pulmonary Disease Drugs Market Concentration Rate
  • 2.5.2 Chronic Obstructive Pulmonary Disease Drugs Market Share of Top 3 and Top 5 Manufacturers
  • 2.5.3 Mergers & Acquisitions, Expansion

3 Global Chronic Obstructive Pulmonary Disease Drugs Production Market Share by Regions

• 3.1 Global Chronic Obstructive Pulmonary Disease Drugs Production Market Share by Regions
• 3.2 Global Chronic Obstructive Pulmonary Disease Drugs Revenue Market Share by Regions (2014-2019)
• 3.3 Global Chronic Obstructive Pulmonary Disease Drugs Production, Revenue, Price and Gross Margin (2014-2019)
• 3.4 North America Chronic Obstructive Pulmonary Disease Drugs Production
  • 3.4.1 North America Chronic Obstructive Pulmonary Disease Drugs Production Growth Rate (2014-2019)
  • 3.4.2 North America Chronic Obstructive Pulmonary Disease Drugs Production, Revenue, Price and Gross Margin (2014-2019)
• 3.5 Europe Chronic Obstructive Pulmonary Disease Drugs Production
  • 3.5.1 Europe Chronic Obstructive Pulmonary Disease Drugs Production Growth Rate (2014-2019)
  • 3.5.2 Europe Chronic Obstructive Pulmonary Disease Drugs Production, Revenue, Price and Gross Margin (2014-2019)
• 3.6 China Chronic Obstructive Pulmonary Disease Drugs Production (2014-2019)
  • 3.6.1 China Chronic Obstructive Pulmonary Disease Drugs Production Growth Rate (2014-2019)
  • 3.6.2 China Chronic Obstructive Pulmonary Disease Drugs Production, Revenue, Price and Gross Margin (2014-2019)
• 3.7 Japan Chronic Obstructive Pulmonary Disease Drugs Production (2014-2019)
  • 3.7.1 Japan Chronic Obstructive Pulmonary Disease Drugs Production Growth Rate (2014-2019)
  • 3.7.2 Japan Chronic Obstructive Pulmonary Disease Drugs Production, Revenue, Price and Gross Margin (2014-2019)

4 Global Chronic Obstructive Pulmonary Disease Drugs Consumption by Regions

• 4.1 Global Chronic Obstructive Pulmonary Disease Drugs Consumption by Regions
• 4.2 North America Chronic Obstructive Pulmonary Disease Drugs Consumption (2014-2019)
• 4.3 Europe Chronic Obstructive Pulmonary Disease Drugs Consumption (2014-2019)
• 4.4 China Chronic Obstructive Pulmonary Disease Drugs Consumption (2014-2019)
• 4.5 Japan Chronic Obstructive Pulmonary Disease Drugs Consumption (2014-2019)

5 Global Chronic Obstructive Pulmonary Disease Drugs Production, Revenue, Price Trend by Type

• 5.1 Global Chronic Obstructive Pulmonary Disease Drugs Production Market Share by Type (2014-2019)
• 5.2 Global Chronic Obstructive Pulmonary Disease Drugs Revenue Market Share by Type (2014-2019)
• 5.3 Global Chronic Obstructive Pulmonary Disease Drugs Price by Type (2014-2019)
• 5.4 Global Chronic Obstructive Pulmonary Disease Drugs Production Growth by Type (2014-2019)

6 Global Chronic Obstructive Pulmonary Disease Drugs Market Analysis by Applications

• 6.1 Global Chronic Obstructive Pulmonary Disease Drugs Consumption Market Share by Application (2014-2019)
• 6.2 Global Chronic Obstructive Pulmonary Disease Drugs Consumption Growth Rate by Application (2014-2019)

7 Company Profiles and Key Figures in Chronic Obstructive Pulmonary Disease Drugs Business

• 7.1 AstraZeneca
  • 7.1.1 AstraZeneca Chronic Obstructive Pulmonary Disease Drugs Production Sites and Area Served
  • 7.1.2 Chronic Obstructive Pulmonary Disease Drugs Product Introduction, Application and Specification
  • 7.1.3 AstraZeneca Chronic Obstructive Pulmonary Disease Drugs Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.1.4 Main Business and Markets Served
• 7.2 Boehringer Ingelheim
  • 7.2.1 Boehringer Ingelheim Chronic Obstructive Pulmonary Disease Drugs Production Sites and Area Served
  • 7.2.2 Chronic Obstructive Pulmonary Disease Drugs Product Introduction, Application and Specification
  • 7.2.3 Boehringer Ingelheim Chronic Obstructive Pulmonary Disease Drugs Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.2.4 Main Business and Markets Served
• 7.3 GSK
  • 7.3.1 GSK Chronic Obstructive Pulmonary Disease Drugs Production Sites and Area Served
  • 7.3.2 Chronic Obstructive Pulmonary Disease Drugs Product Introduction, Application and Specification
  • 7.3.3 GSK Chronic Obstructive Pulmonary Disease Drugs Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.3.4 Main Business and Markets Served
• 7.4 Novartis
  • 7.4.1 Novartis Chronic Obstructive Pulmonary Disease Drugs Production Sites and Area Served
  • 7.4.2 Chronic Obstructive Pulmonary Disease Drugs Product Introduction, Application and Specification
  • 7.4.3 Novartis Chronic Obstructive Pulmonary Disease Drugs Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.4.4 Main Business and Markets Served
• 7.5 Teva Pharmaceuticals
  • 7.5.1 Teva Pharmaceuticals Chronic Obstructive Pulmonary Disease Drugs Production Sites and Area Served
  • 7.5.2 Chronic Obstructive Pulmonary Disease Drugs Product Introduction, Application and Specification
  • 7.5.3 Teva Pharmaceuticals Chronic Obstructive Pulmonary Disease Drugs Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.5.4 Main Business and Markets Served
• 7.6 Ache Laboratorios Farmaceuticos
  • 7.6.1 Ache Laboratorios Farmaceuticos Chronic Obstructive Pulmonary Disease Drugs Production Sites and Area Served
  • 7.6.2 Chronic Obstructive Pulmonary Disease Drugs Product Introduction, Application and Specification
  • 7.6.3 Ache Laboratorios Farmaceuticos Chronic Obstructive Pulmonary Disease Drugs Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.6.4 Main Business and Markets Served
• 7.7 Almirall
  • 7.7.1 Almirall Chronic Obstructive Pulmonary Disease Drugs Production Sites and Area Served
  • 7.7.2 Chronic Obstructive Pulmonary Disease Drugs Product Introduction, Application and Specification
  • 7.7.3 Almirall Chronic Obstructive Pulmonary Disease Drugs Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.7.4 Main Business and Markets Served
• 7.8 Aquinox Pharmaceuticals
  • 7.8.1 Aquinox Pharmaceuticals Chronic Obstructive Pulmonary Disease Drugs Production Sites and Area Served
  • 7.8.2 Chronic Obstructive Pulmonary Disease Drugs Product Introduction, Application and Specification
  • 7.8.3 Aquinox Pharmaceuticals Chronic Obstructive Pulmonary Disease Drugs Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.8.4 Main Business and Markets Served
• 7.9 Ario Pharma
  • 7.9.1 Ario Pharma Chronic Obstructive Pulmonary Disease Drugs Production Sites and Area Served
  • 7.9.2 Chronic Obstructive Pulmonary Disease Drugs Product Introduction, Application and Specification
  • 7.9.3 Ario Pharma Chronic Obstructive Pulmonary Disease Drugs Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.9.4 Main Business and Markets Served
• 7.10 Asmacure
  • 7.10.1 Asmacure Chronic Obstructive Pulmonary Disease Drugs Production Sites and Area Served
  • 7.10.2 Chronic Obstructive Pulmonary Disease Drugs Product Introduction, Application and Specification
  • 7.10.3 Asmacure Chronic Obstructive Pulmonary Disease Drugs Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.10.4 Main Business and Markets Served
• 7.11 Astellas Pharma
• 7.12 BioMarck Pharmaceuticals

8 Chronic Obstructive Pulmonary Disease Drugs Manufacturing Cost Analysis

• 8.1 Chronic Obstructive Pulmonary Disease Drugs Key Raw Materials Analysis
  • 8.1.1 Key Raw Materials
  • 8.1.2 Price Trend of Key Raw Materials
  • 8.1.3 Key Suppliers of Raw Materials
• 8.2 Proportion of Manufacturing Cost Structure
• 8.3 Manufacturing Process Analysis of Chronic Obstructive Pulmonary Disease Drugs
• 8.4 Chronic Obstructive Pulmonary Disease Drugs Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers

• 9.1 Marketing Channel
  • 9.1.1 Direct Marketing
  • 9.1.2 Indirect Marketing
• 9.2 Chronic Obstructive Pulmonary Disease Drugs Distributors List
• 9.3 Chronic Obstructive Pulmonary Disease Drugs Customers

10 Market Dynamics

• 10.1 Market Trends
• 10.2 Opportunities
• 10.3 Market Drivers
• 10.4 Challenges
• 10.5 Influence Factors

11 Global Chronic Obstructive Pulmonary Disease Drugs Market Forecast

• 11.1 Global Chronic Obstructive Pulmonary Disease Drugs Production, Revenue Forecast
  • 11.1.1 Global Chronic Obstructive Pulmonary Disease Drugs Production Growth Rate Forecast (2019-2025)
  • 11.1.2 Global Chronic Obstructive Pulmonary Disease Drugs Revenue and Growth Rate Forecast (2019-2025)
  • 11.1.3 Global Chronic Obstructive Pulmonary Disease Drugs Price and Trend Forecast (2019-2025)
• 11.2 Global Chronic Obstructive Pulmonary Disease Drugs Production Forecast by Regions (2019-2025)
  • 11.2.1 North America Chronic Obstructive Pulmonary Disease Drugs Production, Revenue Forecast (2019-2025)
  • 11.2.2 Europe Chronic Obstructive Pulmonary Disease Drugs Production, Revenue Forecast (2019-2025)
  • 11.2.3 China Chronic Obstructive Pulmonary Disease Drugs Production, Revenue Forecast (2019-2025)
  • 11.2.4 Japan Chronic Obstructive Pulmonary Disease Drugs Production, Revenue Forecast (2019-2025)
• 11.3 Global Chronic Obstructive Pulmonary Disease Drugs Consumption Forecast by Regions (2019-2025)
  • 11.3.1 North America Chronic Obstructive Pulmonary Disease Drugs Consumption Forecast (2019-2025)
  • 11.3.2 Europe Chronic Obstructive Pulmonary Disease Drugs Consumption Forecast (2019-2025)
  • 11.3.3 China Chronic Obstructive Pulmonary Disease Drugs Consumption Forecast (2019-2025)
  • 11.3.4 Japan Chronic Obstructive Pulmonary Disease Drugs Consumption Forecast (2019-2025)
• 11.4 Global Chronic Obstructive Pulmonary Disease Drugs Production, Revenue and Price Forecast by Type (2019-2025)
• 11.5 Global Chronic Obstructive Pulmonary Disease Drugs Consumption Forecast by Application (2019-2025)

12 Research Findings and Conclusion

13 Methodology and Data Source

• 13.1 Methodology/Research Approach
  • 13.1.1 Research Programs/Design
  • 13.1.2 Market Size Estimation
  • 13.1.3 Market Breakdown and Data Triangulation
• 13.2 Data Source
  • 13.2.1 Secondary Sources
  • 13.2.2 Primary Sources
• 13.3 Author List